Medtronic PLC
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.3% | 30.6% | 32.3% | 12.5% | 11.4% | 31.0% | 28.3% | 12.7% | 10.3% | 30.4% | 26.2% | 18.4% | 21.4% | |
| 8.4% | 8.0% | 7.6% | 8.4% | 8.0% | 8.2% | 9.4% | 8.7% | 8.3% | 9.3% | 6.4% | 7.5% | 7.8% | |
| 1.8% | 1.0% | 1.0% | 1.0% | 1.9% | 1.2% | 1.0% | 1.0% | 2.0% | 1.0% | 1.0% | 1.3% | 1.3% | |
| 2.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -13.7% | 6.3% | 10.8% | -11.4% | 10.8% | 5.6% | 5.0% | -13.4% | -15.9% | 7.8% | 4.5% | -6.8% | -2.5% | |
| 5.8% | 4.3% | 5.0% | 6.6% | 4.8% | 5.7% | 5.1% | 5.9% | 5.2% | 4.9% | 5.0% | 5.2% | 5.1% | |
| -5.3% | -8.7% | -8.1% | -3.3% | -4.1% | -10.2% | -5.5% | -8.4% | -5.4% | -9.0% | -9.4% | -16.6% | -10.2% | |
| 11.5% | 11.3% | 10.6% | 11.3% | 10.7% | 10.8% | 10.0% | 10.6% | 10.2% | 10.1% | 9.3% | 9.4% | 9.7% | |
| -2.8% | -1.6% | -19.0% | -31.5% | -3.4% | -2.2% | -3.1% | -1.4% | -4.2% | -1.2% | -4.4% | -2.7% | -3.1% | |
| 10.3% | – | – | – | 6.6% | -12.1% | 0.0% | -6.0% | 8.2% | -13.6% | -1.7% | 8.3% | 0.4% | |
| -1.1% | -18.5% | -27.5% | -9.2% | -6.4% | -21.1% | -15.0% | -16.1% | -4.4% | -23.1% | -9.1% | -3.5% | -9.9% | |
| -0.4% | 3.9% | -3.9% | 0.3% | 1.0% | -1.9% | 11.0% | -11.0% | 0.1% | -1.5% | 8.2% | -2.6% | 1.1% | |
| 2.5% | 26.3% | 27.4% | 5.9% | 6.6% | 25.3% | 23.2% | 6.8% | 5.1% | 25.5% | 21.3% | 13.2% | 16.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.